Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

Inclusion Criteria: * Male or female patient referred to the center for memory impairment. * The memory impairment has previously been observed by a caregiver or documented by a physician. * The memory impairment is confirmed by the memory center. * Caucasian ethnicity. * A written informed consent approved by an ethical review board or similar body must be obtained from the patient prior to any study-related procedures. * If applicable, standard treatment with cholinesterase inhibitor and/or memantine is acceptable. * Patient estimated to be compliant with study procedures. * Patient has a level of understanding sufficient to agree to all procedures required by the protocol and must be able to cooperate. Under no circumstances will a subject who does not understand the procedure, be allowed to consent to the procedure. Exclusion Criteria: * Recent acute pathology or medical condition or surgery which may alter the inflammatory homeostasis, according to the opinion of the investigator. * Non-Caucasian ethnicity. * Patient with severe uncontrolled or unstable medical condition. * Need for a legal representative for the medical condition of the patient. * Any current pathology or medical condition, for which blood sampling may involve a risk for the patient's health, according to the opinion of the investigator. * Current or recent history (within one month) of clinically significant pathology, medical condition (including hospitalization) or symptoms. However, chronic disea…